I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Serological
Transplant Diagnostics by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Serological Transplant
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Serological Transplant
Diagnostics by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Reagents &
Accessories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Reagents & Accessories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Reagents & Accessories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Systems by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Systems by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Systems by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Kidney
Transplantation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Kidney Transplantation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Kidney Transplantation
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Liver
Transplantation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Liver Transplantation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Liver Transplantation
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Heart
Transplantation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Heart Transplantation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Heart Transplantation
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Lung
Transplantation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Lung Transplantation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Lung Transplantation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Hospitals, Blood
Banks & Transplant Centers by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Hospitals, Blood Banks &
Transplant Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Hospitals, Blood Banks &
Transplant Centers by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 28: World Current & Future Analysis for Donor Registries &
Research Laboratories by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Donor Registries & Research
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Donor Registries &
Research Laboratories by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 31: USA Current & Future Analysis for Serological
Transplant Diagnostics by Product Type - Reagents & Accessories
and Systems - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Serological Transplant
Diagnostics by Product Type - Reagents & Accessories and
Systems Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Serological Transplant
Diagnostics by Product Type - Percentage Breakdown of Value
Sales for Reagents & Accessories and Systems for the Years
2012, 2020 & 2027

Table 34: USA Current & Future Analysis for Serological
Transplant Diagnostics by Application - Kidney Transplantation,
Liver Transplantation, Heart Transplantation, Lung
Transplantation and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 35: USA Historic Review for Serological Transplant
Diagnostics by Application - Kidney Transplantation, Liver
Transplantation, Heart Transplantation, Lung Transplantation
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Serological Transplant
Diagnostics by Application - Percentage Breakdown of Value
Sales for Kidney Transplantation, Liver Transplantation, Heart
Transplantation, Lung Transplantation and Other Applications
for the Years 2012, 2020 & 2027

Table 37: USA Current & Future Analysis for Serological
Transplant Diagnostics by End-Use - Hospitals, Blood Banks &
Transplant Centers and Donor Registries & Research Laboratories -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 38: USA Historic Review for Serological Transplant
Diagnostics by End-Use - Hospitals, Blood Banks & Transplant
Centers and Donor Registries & Research Laboratories Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 39: USA 15-Year Perspective for Serological Transplant
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Blood Banks & Transplant Centers and Donor
Registries & Research Laboratories for the Years 2012, 2020 &
2027

CANADA
Table 40: Canada Current & Future Analysis for Serological
Transplant Diagnostics by Product Type - Reagents & Accessories
and Systems - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 41: Canada Historic Review for Serological Transplant
Diagnostics by Product Type - Reagents & Accessories and
Systems Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 42: Canada 15-Year Perspective for Serological Transplant
Diagnostics by Product Type - Percentage Breakdown of Value
Sales for Reagents & Accessories and Systems for the Years
2012, 2020 & 2027

Table 43: Canada Current & Future Analysis for Serological
Transplant Diagnostics by Application - Kidney Transplantation,
Liver Transplantation, Heart Transplantation, Lung
Transplantation and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 44: Canada Historic Review for Serological Transplant
Diagnostics by Application - Kidney Transplantation, Liver
Transplantation, Heart Transplantation, Lung Transplantation
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for Serological Transplant
Diagnostics by Application - Percentage Breakdown of Value
Sales for Kidney Transplantation, Liver Transplantation, Heart
Transplantation, Lung Transplantation and Other Applications
for the Years 2012, 2020 & 2027

Table 46: Canada Current & Future Analysis for Serological
Transplant Diagnostics by End-Use - Hospitals, Blood Banks &
Transplant Centers and Donor Registries & Research Laboratories -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: Canada Historic Review for Serological Transplant
Diagnostics by End-Use - Hospitals, Blood Banks & Transplant
Centers and Donor Registries & Research Laboratories Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for Serological Transplant
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Blood Banks & Transplant Centers and Donor
Registries & Research Laboratories for the Years 2012, 2020 &
2027

JAPAN
Table 49: Japan Current & Future Analysis for Serological
Transplant Diagnostics by Product Type - Reagents & Accessories
and Systems - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 50: Japan Historic Review for Serological Transplant
Diagnostics by Product Type - Reagents & Accessories and
Systems Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 51: Japan 15-Year Perspective for Serological Transplant
Diagnostics by Product Type - Percentage Breakdown of Value
Sales for Reagents & Accessories and Systems for the Years
2012, 2020 & 2027

Table 52: Japan Current & Future Analysis for Serological
Transplant Diagnostics by Application - Kidney Transplantation,
Liver Transplantation, Heart Transplantation, Lung
Transplantation and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 53: Japan Historic Review for Serological Transplant
Diagnostics by Application - Kidney Transplantation, Liver
Transplantation, Heart Transplantation, Lung Transplantation
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for Serological Transplant
Diagnostics by Application - Percentage Breakdown of Value
Sales for Kidney Transplantation, Liver Transplantation, Heart
Transplantation, Lung Transplantation and Other Applications
for the Years 2012, 2020 & 2027

Table 55: Japan Current & Future Analysis for Serological
Transplant Diagnostics by End-Use - Hospitals, Blood Banks &
Transplant Centers and Donor Registries & Research Laboratories -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: Japan Historic Review for Serological Transplant
Diagnostics by End-Use - Hospitals, Blood Banks & Transplant
Centers and Donor Registries & Research Laboratories Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 57: Japan 15-Year Perspective for Serological Transplant
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Blood Banks & Transplant Centers and Donor
Registries & Research Laboratories for the Years 2012, 2020 &
2027

CHINA
Table 58: China Current & Future Analysis for Serological
Transplant Diagnostics by Product Type - Reagents & Accessories
and Systems - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 59: China Historic Review for Serological Transplant
Diagnostics by Product Type - Reagents & Accessories and
Systems Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for Serological Transplant
Diagnostics by Product Type - Percentage Breakdown of Value
Sales for Reagents & Accessories and Systems for the Years
2012, 2020 & 2027

Table 61: China Current & Future Analysis for Serological
Transplant Diagnostics by Application - Kidney Transplantation,
Liver Transplantation, Heart Transplantation, Lung
Transplantation and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 62: China Historic Review for Serological Transplant
Diagnostics by Application - Kidney Transplantation, Liver
Transplantation, Heart Transplantation, Lung Transplantation
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 63: China 15-Year Perspective for Serological Transplant
Diagnostics by Application - Percentage Breakdown of Value
Sales for Kidney Transplantation, Liver Transplantation, Heart
Transplantation, Lung Transplantation and Other Applications
for the Years 2012, 2020 & 2027

Table 64: China Current & Future Analysis for Serological
Transplant Diagnostics by End-Use - Hospitals, Blood Banks &
Transplant Centers and Donor Registries & Research Laboratories -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 65: China Historic Review for Serological Transplant
Diagnostics by End-Use - Hospitals, Blood Banks & Transplant
Centers and Donor Registries & Research Laboratories Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 66: China 15-Year Perspective for Serological Transplant
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Blood Banks & Transplant Centers and Donor
Registries & Research Laboratories for the Years 2012, 2020 &
2027

EUROPE
Table 67: Europe Current & Future Analysis for Serological
Transplant Diagnostics by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Serological Transplant
Diagnostics by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 69: Europe 15-Year Perspective for Serological Transplant
Diagnostics by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2012, 2020 & 2027

Table 70: Europe Current & Future Analysis for Serological
Transplant Diagnostics by Product Type - Reagents & Accessories
and Systems - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 71: Europe Historic Review for Serological Transplant
Diagnostics by Product Type - Reagents & Accessories and
Systems Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Serological Transplant
Diagnostics by Product Type - Percentage Breakdown of Value
Sales for Reagents & Accessories and Systems for the Years
2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Serological
Transplant Diagnostics by Application - Kidney Transplantation,
Liver Transplantation, Heart Transplantation, Lung
Transplantation and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 74: Europe Historic Review for Serological Transplant
Diagnostics by Application - Kidney Transplantation, Liver
Transplantation, Heart Transplantation, Lung Transplantation
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Serological Transplant
Diagnostics by Application - Percentage Breakdown of Value
Sales for Kidney Transplantation, Liver Transplantation, Heart
Transplantation, Lung Transplantation and Other Applications
for the Years 2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Serological
Transplant Diagnostics by End-Use - Hospitals, Blood Banks &
Transplant Centers and Donor Registries & Research Laboratories -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 77: Europe Historic Review for Serological Transplant
Diagnostics by End-Use - Hospitals, Blood Banks & Transplant
Centers and Donor Registries & Research Laboratories Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 78: Europe 15-Year Perspective for Serological Transplant
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Blood Banks & Transplant Centers and Donor
Registries & Research Laboratories for the Years 2012, 2020 &
2027

FRANCE
Table 79: France Current & Future Analysis for Serological
Transplant Diagnostics by Product Type - Reagents & Accessories
and Systems - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 80: France Historic Review for Serological Transplant
Diagnostics by Product Type - Reagents & Accessories and
Systems Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 81: France 15-Year Perspective for Serological Transplant
Diagnostics by Product Type - Percentage Breakdown of Value
Sales for Reagents & Accessories and Systems for the Years
2012, 2020 & 2027

Table 82: France Current & Future Analysis for Serological
Transplant Diagnostics by Application - Kidney Transplantation,
Liver Transplantation, Heart Transplantation, Lung
Transplantation and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 83: France Historic Review for Serological Transplant
Diagnostics by Application - Kidney Transplantation, Liver
Transplantation, Heart Transplantation, Lung Transplantation
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 84: France 15-Year Perspective for Serological Transplant
Diagnostics by Application - Percentage Breakdown of Value
Sales for Kidney Transplantation, Liver Transplantation, Heart
Transplantation, Lung Transplantation and Other Applications
for the Years 2012, 2020 & 2027

Table 85: France Current & Future Analysis for Serological
Transplant Diagnostics by End-Use - Hospitals, Blood Banks &
Transplant Centers and Donor Registries & Research Laboratories -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 86: France Historic Review for Serological Transplant
Diagnostics by End-Use - Hospitals, Blood Banks & Transplant
Centers and Donor Registries & Research Laboratories Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 87: France 15-Year Perspective for Serological Transplant
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Blood Banks & Transplant Centers and Donor
Registries & Research Laboratories for the Years 2012, 2020 &
2027

GERMANY
Table 88: Germany Current & Future Analysis for Serological
Transplant Diagnostics by Product Type - Reagents & Accessories
and Systems - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 89: Germany Historic Review for Serological Transplant
Diagnostics by Product Type - Reagents & Accessories and
Systems Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 90: Germany 15-Year Perspective for Serological
Transplant Diagnostics by Product Type - Percentage Breakdown
of Value Sales for Reagents & Accessories and Systems for the
Years 2012, 2020 & 2027

Table 91: Germany Current & Future Analysis for Serological
Transplant Diagnostics by Application - Kidney Transplantation,
Liver Transplantation, Heart Transplantation, Lung
Transplantation and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 92: Germany Historic Review for Serological Transplant
Diagnostics by Application - Kidney Transplantation, Liver
Transplantation, Heart Transplantation, Lung Transplantation
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 93: Germany 15-Year Perspective for Serological
Transplant Diagnostics by Application - Percentage Breakdown of
Value Sales for Kidney Transplantation, Liver Transplantation,
Heart Transplantation, Lung Transplantation and Other
Applications for the Years 2012, 2020 & 2027

Table 94: Germany Current & Future Analysis for Serological
Transplant Diagnostics by End-Use - Hospitals, Blood Banks &
Transplant Centers and Donor Registries & Research Laboratories -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 95: Germany Historic Review for Serological Transplant
Diagnostics by End-Use - Hospitals, Blood Banks & Transplant
Centers and Donor Registries & Research Laboratories Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 96: Germany 15-Year Perspective for Serological
Transplant Diagnostics by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Blood Banks & Transplant Centers and
Donor Registries & Research Laboratories for the Years 2012,
2020 & 2027

ITALY
Table 97: Italy Current & Future Analysis for Serological
Transplant Diagnostics by Product Type - Reagents & Accessories
and Systems - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 98: Italy Historic Review for Serological Transplant
Diagnostics by Product Type - Reagents & Accessories and
Systems Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 99: Italy 15-Year Perspective for Serological Transplant
Diagnostics by Product Type - Percentage Breakdown of Value
Sales for Reagents & Accessories and Systems for the Years
2012, 2020 & 2027

Table 100: Italy Current & Future Analysis for Serological
Transplant Diagnostics by Application - Kidney Transplantation,
Liver Transplantation, Heart Transplantation, Lung
Transplantation and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 101: Italy Historic Review for Serological Transplant
Diagnostics by Application - Kidney Transplantation, Liver
Transplantation, Heart Transplantation, Lung Transplantation
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 102: Italy 15-Year Perspective for Serological Transplant
Diagnostics by Application - Percentage Breakdown of Value
Sales for Kidney Transplantation, Liver Transplantation, Heart
Transplantation, Lung Transplantation and Other Applications
for the Years 2012, 2020 & 2027

Table 103: Italy Current & Future Analysis for Serological
Transplant Diagnostics by End-Use - Hospitals, Blood Banks &
Transplant Centers and Donor Registries & Research Laboratories -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 104: Italy Historic Review for Serological Transplant
Diagnostics by End-Use - Hospitals, Blood Banks & Transplant
Centers and Donor Registries & Research Laboratories Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 105: Italy 15-Year Perspective for Serological Transplant
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Blood Banks & Transplant Centers and Donor
Registries & Research Laboratories for the Years 2012, 2020 &
2027

UNITED KINGDOM
Table 106: UK Current & Future Analysis for Serological
Transplant Diagnostics by Product Type - Reagents & Accessories
and Systems - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 107: UK Historic Review for Serological Transplant
Diagnostics by Product Type - Reagents & Accessories and
Systems Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 108: UK 15-Year Perspective for Serological Transplant
Diagnostics by Product Type - Percentage Breakdown of Value
Sales for Reagents & Accessories and Systems for the Years
2012, 2020 & 2027

Table 109: UK Current & Future Analysis for Serological
Transplant Diagnostics by Application - Kidney Transplantation,
Liver Transplantation, Heart Transplantation, Lung
Transplantation and Other Applications - Independent Analysis
of Annual Sales in US$ Thousa